Search results for "Cost-benefit analysi"

showing 10 items of 148 documents

Clinical and economic impact of pharmacist interventions in an ambulatory hematology–oncology department

2020

Objectives To evaluate clinical and financial impact of pharmacist interventions in an ambulatory adult hematology–oncology department. Methods All cancer patients receiving a first injectable immuno- and/or chemotherapy regimen were included in this prospective study over a one-year period. The clinical impact of pharmacist interventions made by two clinical pharmacists was rated using the Clinical Economic and Organizational tool. Financial impact was calculated through cost savings and cost avoidance. Main results: Five hundred and fifty-eight patients were included. A total of 1970 pharmacist interventions were performed corresponding to a mean number of 3.5 pharmacist interventions/pat…

Malemedicine.medical_specialtyCost-Benefit AnalysiseducationPharmacistsAmbulatory Care Facilities03 medical and health sciences0302 clinical medicineCost SavingsNeoplasmsHumansMedicinePharmacology (medical)Prospective Studies030212 general & internal medicineEconomic impact analysishealth care economics and organizationsPharmacist interventionAgedAged 80 and overPatient care teambusiness.industryFinancial impactCancerMiddle Agedmedicine.diseaseCost savingsOncology030220 oncology & carcinogenesisFamily medicineAmbulatoryFemalePharmacy Service HospitalbusinessHematology+OncologyJournal of Oncology Pharmacy Practice
researchProduct

Epidemiology, prevention and screening for prostate cancer.

1996

Prostate cancer is a growing social problem. The economical impact is high and is likely to become greater in future years, not only because the number of patients diagnosed with prostatic neoplasias is increasing steadily, but also because of the promotion of screening programmes and the rise in the number of surgical procedures available. It can be concluded that, at the present stage, widespread implementation of screening cannot be recommended. The answer to the question of screening can only be provided by large randomised trials, comparing either screening versus no screening, or early versus delayed treatment in patients in whom early cancer is detected by screening.

Malemedicine.medical_specialtyEarly cancerUrologyCost-Benefit AnalysisRisk AssessmentProstate cancerEpidemiologymedicineHumansMass ScreeningIn patientStage (cooking)Intensive care medicineRandomized Controlled Trials as TopicPalpationbusiness.industryRectumProstatic NeoplasmsDelayed treatmentSurgical proceduresMiddle AgedProstate-Specific Antigenmedicine.diseasePrimary PreventionPhysical therapybusinessEuropean urology
researchProduct

Efficacy and Cost-Effectiveness of Dabigatran Etexilate Versus Warfarin in Atrial Fibrillation in Different Age Subgroups

2014

This study aims to estimate the cost-effectiveness of dabigatran 150 mg twice daily versus warfarin for stroke and systemic embolism risk reduction in patients with nonvalvular atrial fibrillation initiating treatment before age 75 (<75), at or after age 75 (≥75), and the overall population (All) from a US Medicare payer perspective. Clinical event rates by age cohort with dabigatran or warfarin for safety-on-treatment and intent-to-treat populations were estimated from Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY). An economic model was adapted using these data to evaluate the impact of starting age on clinical and economic outcomes. Costs were obtained from Medicare p…

Malemedicine.medical_specialtyTime FactorsCost effectivenessCost-Benefit AnalysisMedicareAntithrombinsDrug Administration ScheduleDrug CostsDabigatranThromboembolismInternal medicineAtrial FibrillationmedicineHumansIn patientcardiovascular diseasesStrokeAgedbusiness.industryIncidenceFollow up studiesWarfarinSystemic embolismAtrial fibrillationPrognosismedicine.diseaseUnited StatesDabigatranbeta-AlanineCardiologyBenzimidazolesFemalebusinessCardiology and Cardiovascular MedicineFollow-Up Studiesmedicine.drugThe American Journal of Cardiology
researchProduct

Costs and Benefits of Orthographic Inconsistency in Reading: Evidence from a Cross-Linguistic Comparison.

2016

We compared reading acquisition in English and Italian children up to late primary school analyzing RTs and errors as a function of various psycholinguistic variables and changes due to experience. Our results show that reading becomes progressively more reliant on larger processing units with age, but that this is modulated by consistency of the language. In English, an inconsistent orthography, reliance on larger units occurs earlier on and it is demonstrated by faster RTs, a stronger effect of lexical variables and lack of length effect (by fifth grade). However, not all English children are able to master this mode of processing yielding larger inter-individual variability. In Italian, …

Maleorthographic consistencyCost-Benefit AnalysisSocial Scienceslcsh:MedicineAcademic SkillsPsycholinguisticsLiteracyFamilies0302 clinical medicineSociologyReading (process)PsychologyEthnicitiesChildlcsh:ScienceChildrenreading; cross-linguistic; orthographymedia_commonLanguageorthographyMultidisciplinaryPsycholinguisticsSchoolsCost–benefit analysis05 social sciencesOrthographic projectionSyllablescross-linguisticItalian PeopleLanguage developmentEnglandItalyFemalePsychologyCognitive psychologyCross linguisticResearch Articlemedia_common.quotation_subjectPhonologyLanguage Development050105 experimental psychologyEducation03 medical and health sciencesLiteracyReading acquisitionHumans0501 psychology and cognitive scienceslcsh:RCognitive PsychologyBiology and Life SciencesPhonemesReproducibility of ResultsLinguisticsReadingAge Groupscross-linguistic comparisonPeople and PlacesCognitive SciencePopulation Groupingslcsh:Q030217 neurology & neurosurgeryOrthographyNeurosciencePLoS ONE
researchProduct

New Challenges of Economic and Business Development – 2012 : Conference Proceedings (May 10 - 12, 2012, Riga, University of Latvia)

2012

Support for Conference Proceedings by ERAF Project "Support for the international cooperation projects and other international cooperation activities in research and technology at the University of Latvia" No. 2010/0202/2DP/2.1.1.2.0/10/APIA/VIAA/013

Market efficiencyInternational franchisingTriple Helix modelOptimal capital structureLogisticsGDPTeam PerformanceManagement theoryTourismAirline industryStakeholdersInsurance marketsNew Product DevelopmentRisksHuman capitalMunicipality budgetMarketingDevelopment economicsResearch policyCost-benefit analysisBusiness groupsOrganizational developmentMergers and acquisitionsInternational rating agencyCompliance Management SystemsRegional integrationKnowledge sharingFinancial scienceWell-beingBargain purchaseTax wedgeFinancial managementEducationEmployee selectionMonetary policyCorporate cultureHigher educationCitizen participationInnovationMotivationOnline surveysManagement educationEmployer BrandingBrand imageFinancial analysisInternal auditPrint advertisement assessmentICT:SOCIAL SCIENCES::Business and economics [Research Subject Categories]Environmental management accountingFinancial system stabilityEmployee satisfactionBanking sectorSocial MediaPension system
researchProduct

Bayesian methods in cost-effectiveness studies: objectivity, computation and other relevant aspects.

2009

In a probabilistic sensitivity analysis (PSA) of a cost-effectiveness (CE) study, the unknown parameters are considered as random variables. A crucial question is what probabilistic distribution is suitable for synthesizing the available information (mainly data from clinical trials) about these parameters. In this context, the important role of Bayesian methodology has been recognized, where the parameters are of a random nature. We explore, in the context of CE analyses, how formal objective Bayesian methods can be implemented. We fully illustrate the methodology using two CE problems that frequently appear in the CE literature. The results are compared with those obtained with other popu…

Markov chainComputer scienceCost effectivenessHealth PolicyCost-Benefit AnalysisBayesian probabilityAnti-Inflammatory Agents Non-SteroidalProbabilistic logicContext (language use)Bayes Theoremcomputer.software_genreMarkov ChainsDecision Support TechniquesBayes' theoremOsteoarthritisHumansSensitivity (control systems)Data miningRandom variablecomputerMonte Carlo MethodHealth economics
researchProduct

Potencial sesgo de patrocinio en los análisis coste-efectividad de intervenciones sanitarias: un análisis transversal

2017

Resumen Objetivo Examinar la relación entre la fuente de financiación de los análisis coste-efectividad de intervenciones sanitarias publicados en España y las conclusiones de los estudios. Diseño Estudio descriptivo transversal. Emplazamiento Bases de datos de literatura científica (hasta diciembre de 2014). Participantes (unidad de análisis) Cohorte de análisis coste-efectividad de intervenciones sanitarias publicados en España entre 1989-2014 (n = 223) que presentaran como medida de resultado los años de vida ajustados por calidad (AVAC). Mediciones principales Se establecieron relaciones entre las conclusiones cualitativas de los estudios y el tipo de fuente de financiación utilizando l…

Medicine(all)lcsh:R5-920Años de vida ajustados por calidad030505 public healthCoste-efectividadCost-Benefit AnalysisEspañaGeneral MedicineOriginalesSesgo03 medical and health sciences0302 clinical medicineCross-Sectional StudiesBiasSpainHumansCost-effectivenessQuality-adjusted life years030212 general & internal medicinelcsh:Medicine (General)0305 other medical scienceFamily PracticeDelivery of Health CareAtencion Primaria
researchProduct

Assessing disproportionate costs to achieve good ecological status of water bodies in a Mediterranean river basin.

2011

Water management is becoming increasingly important as the demand for water grows, diversifies, and includes more complex environmental concerns. The Water Framework Directive (WFD) seeks to achieve a good ecological status for all European Community water bodies by 2015. To achieve this objective, economic consideration of water management must be given to all decision-making processes. Exemption (time or level of stringency) from the objectives of the EU Directive can be justified by proving that the cost of implementing measures is disproportionate to the benefits. This paper addresses the issue of disproportionate costs through a cost-benefit analysis (CBA). To predict the costs, the fu…

Mediterranean climategeographygeography.geographical_feature_categoryEuropean communityEcologyCost-Benefit AnalysisWater PollutionPublic Health Environmental and Occupational HealthDrainage basinGeneral MedicineManagement Monitoring Policy and LawDirectiveWater PurificationWater Framework DirectiveRiversSpainBusinessWater qualityValuation (finance)Environmental MonitoringJournal of environmental monitoring : JEM
researchProduct

Cost-Effectiveness of Pneumococcal Vaccination of Older People: A Study in 5 Western European Countries

1999

Pneumococcal vaccination of older persons is thought to be cost-effective in preventing pneumococcal pneumonia, but evidence of clinical protection is uncertain. Because there is better evidence of vaccination effectiveness against invasive pneumococcal disease, we determined the cost-effectiveness of pneumococcal vaccination of persons agedor =65 years in preventing hospital admission for both invasive pneumococcal disease and pneumococcal pneumonia in 5 western European countries. In the base case analyses, the cost-effectiveness ratios for preventing invasive disease varied from approximately 11,000 to approximately 33,000 European currency units (ecu) per quality-adjusted life year (QAL…

Microbiology (medical)medicine.medical_specialtyPediatricsCost effectivenessCost-Benefit AnalysisPneumococcal VaccinesmedicineHumansAgedAged 80 and overbusiness.industryIncidenceMortality rateIncidence (epidemiology)VaccinationPneumonia Pneumococcalmedicine.diseaseQuality-adjusted life yearSurgeryEuropeVaccinationPneumoniaInfectious DiseasesPneumococcal vaccinePneumococcal pneumoniaQuality-Adjusted Life YearsbusinessClinical Infectious Diseases
researchProduct

Handheld and cost-effective Fourier lightfield microscope

2022

In this work, the design, building, and testing of the most portable, easy-to-build, robust, handheld, and cost-effective Fourier Lightfield Microscope (FLMic) to date is reported. The FLMic is built by means of a surveillance camera lens and additional off-the-shelf optical elements, resulting in a cost-effective FLMic exhibiting all the regular sought features in lightfield microscopy, such as refocusing and gathering 3D information of samples by means of a single-shot approach. The proposed FLMic features reduced dimensions and light weight, which, combined with its low cost, turn the presented FLMic into a strong candidate for in-field application where 3D imaging capabilities are pursu…

MicroscopyMicroscòpiaImaging Three-Dimensionalmicroscopy; light-field; 3D imagingCost-Benefit AnalysisElectrical and Electronic EngineeringÒpticaBiochemistryInstrumentationAtomic and Molecular Physics and OpticsAnalytical Chemistry
researchProduct